Voronoi, Inc. (KOSDAQ:310210)

South Korea flag South Korea · Delayed Price · Currency is KRW
107,200
+1,000 (0.94%)
Feb 21, 2025, 3:30 PM KST
172.08%
Market Cap 1.92T
Revenue (ttm) n/a
Net Income (ttm) -38.88B
Shares Out 17.95M
EPS (ttm) -2,254.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 178,492
Average Volume 266,011
Open 105,000
Previous Close 106,200
Day's Range 103,100 - 111,400
52-Week Range 28,350 - 125,900
Beta 1.99
RSI 55.94
Earnings Date Feb 14, 2025

About Voronoi

Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid arthritis and atopic dermatitis. The company’s products pipeline also comprise VRN04-1 to treat autoimmune diseases; VRN04-2 for the treatment of multipl... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2015
Employees 130
Stock Exchange KOSDAQ
Ticker Symbol 310210
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.